Acamprosate Appears Safe for People With AUD and Liver Disease
(MedPage Today) -- WASHINGTON -- Acamprosate (Campral) was safe to use in people with liver disease, a phase II study showed. Among people with alcohol use disorder (AUD) and alcohol-associated liver disease, acamprosate was safe, well-tolerated... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 9, 2022 Category: Psychiatry Source Type: news

Medication-Assisted Treatment Needs Community Support
Communities like Portsmouth, Ohio, regularly make national news for waves of overdoses. On any given day, nearly 100 people across the country die due to opioid overdose. The problem always feels like an uphill battle, and often a losing one for social workers and drug counselors who hope to get clients on the path to sobriety. Evidence shows that one method, medication assisted treatment (MAT), works; however, for MAT to be truly effective, it takes an entire community. What Is Medication Assisted Treatment? Medication assisted treatment is an evidence-based recovery process that combines traditional therapies and detox p...
Source: Psych Central - April 23, 2018 Category: Psychiatry Authors: Desiree Patton Tags: Addictions Alcoholism Medications Stigma Substance Abuse Addiction Treatment buprenorphine probuphine methadone naloxone naltrexone acamprosate evidence-based treatment medication-assisted treatment recovery Source Type: news

Campral (Acamprosate Calcium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 1, 2016 Category: Drugs & Pharmacology Source Type: news

Glenmark gets USFDA nod for alcohol abstinence drug
Glenmark Pharma said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed Release Tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 12, 2013 Category: Pharmaceuticals Source Type: news